Ads
related to: Regeneron Pharmaceuticals- Genetic Research
Speeding Drug Discovery
Learn about the RGC
- Antibodies at Work
End-to-End Research & Development
See Regeneron's Approved Medicines
- About Regeneron
Industry-Leading Biotechnology
Reinventing Drug Discovery
- Science & Technology
See Regeneron's New Technology
Turning Science into Medicine
- Genetic Research
Search results
Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's Recent Performance A Reflection Of Its...
Simply Wall St. via Yahoo Finance· 11 hours agoRegeneron Pharmaceuticals' (NASDAQ:REGN) stock up by 4.9% over the past month. Since the market...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by First National Bank of Omaha
ETF DAILY NEWS· 11 hours agoFirst National Bank of Omaha reduced its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.1% in the 4th quarter, according ...
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) the Best Bet in Gene Therapy Industry?
Insider Monkey via Yahoo Finance· 5 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Navigating 14 Analyst Ratings For Regeneron Pharmaceuticals - Regeneron Pharmaceuticals...
Benzinga· 4 days agoLoading... Loading... Throughout the last three months, 14 analysts have evaluated Regeneron Pharmaceuticals REGN , offering a diverse set of opinions from ...
...FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate...
Benzinga· 5 days agoFibroGen to evaluate FG-3165, an anti-galectin 9 (Gal9) monoclonal antibody (mAb), as monotherapy treatment as well as in combination with LIBTAYO® in patients with select solid tumorsFibroGen to evaluate FG-3175,
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 1 day agoVertex, One Of The Biggest Biotech Stocks Vertex is among the biggest biotech stocks in terms of...
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside - Regenxbio...
Benzinga· 1 day agoGoldman Sachs initiates coverage on RGNX, citing potential of gene therapy platform.
3 Stocks to Watch in Active Growth ETF FDG | ETF Trends
ETF Trends· 4 days agoIn this case, the American Century Focused Dynamic Growth ETF (FDG) could appeal, with three stocks...
22 CEOs who founded their Fortune 500 companies
Fortune via Yahoo Finance· 4 days agoHe and his fellow co-founders focused on the buy-side of trading, and integrated investing with risk management. Leonard S. Schleifer Company: Regeneron ...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 3 days agoNEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. (“Regeneron” ...
